Search Results - C. Legon
- Showing 1 - 3 results of 3
-
1
-
2
-
3
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative c... by Christian Pfister, Valentin Harter, Yves Allory, François Radvanyi, Stéphane Culine, G. Grawis, G. Pignot, A. Flechon, J.P. Fendler, C. Chevreau, M. Soulie, H. Mahammedi, L. Guy, B. Laguerre, G. Verhoest, A. Guillot, N. Mottet, F. Joly, A. Doerfler, S. Abadie-Lacourtoisie, A.R. Azzouzi, P. Mongiat, L. Geoffrois, P. Eschwege, F. Di Fiore, G. Roubaud, J.L. Hoepffner, P. Barthelemy, H. Lang, E. Voog, E. Mandron, J.M. Tourani, C. Serrrate, A. Colau, C. Saldana, A. de La Taille, T. Nguyen, F. Kleinclauss, Y. Loriot, J. Irani, J.C. Eymard, S. Larre, O. Huillard, M. Zerbib, F. Rolland, J. Rigaud, N. Houede, S. Droupy, G. Malouf, M. Roupret, M. El Demery, C. Legon, S. Vieillot, N. Letang, T. Lharidon, N. Gaschignard, W. Hilgers, J.L. Davin
Published in Contemporary Clinical Trials Communications (2020-03-01)Get full text
Article
